Search

everythinglearnresearchcommunity

for

Search:↓

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

Understanding glycans and enzymes that alter them is key to controlling hair growth.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Men are more affected by COVID-19 due to differences in immune responses and protein expression.

Testosterone may both worsen and protect against COVID-19 effects in men.

Certain mutations in the PADI3 gene may increase the risk of developing a type of scarring hair loss common in women of African descent.

Terbinafine is more effective than itraconazole for toenail fungus, especially in older patients, and debridement improves its effectiveness.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Spanlastic formulations improve rivaroxaban's oral anticoagulation efficiency.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Men have higher COVID-19 mortality rates than women due to biological and lifestyle factors.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

A new mutation in the ST14 gene causes a rare skin and hair disorder in a specific family.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Pannexin 3 helps skin and hair growth by controlling a protein called Epiprofin.

Hair loss doesn't affect COVID-19 severity.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

Androgens can both increase and decrease hair growth in different parts of the body.

Stress increases a factor in mice that leads to hair loss, and blocking this factor may prevent it.

XEDAR triggers a specific signaling pathway in cells.

Leucaena seeds are nutritious but need treatment to reduce toxicity.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.